HK1180213A1 - Methods for treating diabetic foot ulcers - Google Patents

Methods for treating diabetic foot ulcers

Info

Publication number
HK1180213A1
HK1180213A1 HK13107412.0A HK13107412A HK1180213A1 HK 1180213 A1 HK1180213 A1 HK 1180213A1 HK 13107412 A HK13107412 A HK 13107412A HK 1180213 A1 HK1180213 A1 HK 1180213A1
Authority
HK
Hong Kong
Prior art keywords
methods
diabetic foot
foot ulcers
treating diabetic
ulcers
Prior art date
Application number
HK13107412.0A
Other languages
English (en)
Chinese (zh)
Inventor
Kathleen E Rodgers
Gere S Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45571822&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1180213(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of HK1180213A1 publication Critical patent/HK1180213A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
HK13107412.0A 2011-02-02 2013-06-25 Methods for treating diabetic foot ulcers HK1180213A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161438780P 2011-02-02 2011-02-02
PCT/US2012/023484 WO2012106427A2 (fr) 2011-02-02 2012-02-01 Procédés de traitement d'ulcères du pied diabétique

Publications (1)

Publication Number Publication Date
HK1180213A1 true HK1180213A1 (en) 2013-10-18

Family

ID=45571822

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107412.0A HK1180213A1 (en) 2011-02-02 2013-06-25 Methods for treating diabetic foot ulcers

Country Status (21)

Country Link
US (3) US8207233B1 (fr)
EP (1) EP2536422B8 (fr)
JP (2) JP5469777B2 (fr)
KR (1) KR101514414B1 (fr)
CN (1) CN102858360B (fr)
AU (1) AU2012212220B2 (fr)
BR (1) BR112013019513A2 (fr)
CA (1) CA2793515C (fr)
CL (1) CL2012002560A1 (fr)
CO (1) CO6592101A2 (fr)
DK (1) DK2536422T3 (fr)
EA (1) EA026440B1 (fr)
ES (1) ES2479765T3 (fr)
HK (1) HK1180213A1 (fr)
MX (1) MX2012010783A (fr)
PE (1) PE20130379A1 (fr)
PL (1) PL2536422T3 (fr)
PT (1) PT2536422E (fr)
SG (1) SG183960A1 (fr)
WO (1) WO2012106427A2 (fr)
ZA (1) ZA201207340B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012010783A (es) * 2011-02-02 2012-11-23 Univ Southern California Metodos para tratar ulceras del pie diabetico.
EP2849773A1 (fr) 2012-05-14 2015-03-25 University of Southern California Procédés pour limiter le développement d'une plaie cutanée
CA2884792A1 (fr) * 2012-09-17 2014-03-20 Tarix Pharmaceuticals Ltd. Compositions orales a base d'angiotensine
US9289500B2 (en) * 2013-02-22 2016-03-22 The Regents Of The University Of California Saccharide-peptide hydrogels
CA2902619A1 (fr) 2013-03-15 2014-09-25 University Of Southern California Methodes de traitement de la sclerose en plaques
EP2967049B1 (fr) 2013-03-15 2020-09-02 University Of Southern California Procédés, composés et compositions pour le traitement de maladies liées à l'angiotensine
US9981011B2 (en) * 2014-03-10 2018-05-29 Rush University Medical Center Methods of promotion of healing of diabetic wounds
WO2016108130A1 (fr) * 2014-12-30 2016-07-07 Sun Pharmaceutical Industries Limited Compositions pharmaceutiques topiques comprenant du nébivolol pour le traitement de plaies diabétiques
WO2017100276A1 (fr) * 2015-12-08 2017-06-15 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions et méthodes pour traiter, soulager et prévenir des ulcères de la peau associés au diabète
US20240092886A1 (en) * 2019-10-09 2024-03-21 Rush University Medical Center Modulating interleukin-10 signaling to boost healing in diabetic wounds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015629A (en) 1989-06-26 1991-05-14 University Of Southern California Tissue repair
WO1993008825A1 (fr) * 1991-11-04 1993-05-13 Zymogenetics, Inc. Formulation d'un gel de fcdp
US5955430A (en) 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
WO1995008565A1 (fr) 1993-09-24 1995-03-30 The University Of Southern California Utilisation d'analogues d'angiotensine ii pour la reparation tissulaire
ES2168312T3 (es) 1993-09-24 2002-06-16 Univ Southern California Utilizacion de angiotensina iii y sus analogos para la reparacion tisular.
US5834432A (en) 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
US6110895A (en) 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en) 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
WO1999031125A1 (fr) 1997-12-12 1999-06-24 University Of Southern California Compositions de cicatrisation
CA2321168A1 (fr) 1998-02-09 1999-08-12 University Of Southern California Activation de la proliferation des keratinocytes
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
US6498138B1 (en) 1998-03-11 2002-12-24 University Of Southern California Method of promoting production of living tissue equivalents
EP1073453B1 (fr) 1998-05-11 2005-04-13 University Of Southern California Utilisation d'analogues de l'angiotensine pour la preparation d'un medicament pour l'augmentation du taux de survie des globules blancs et pour la mobilisation de cellules souche hematopoietiques apres une chimiotherapie
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
AU756785B2 (en) 1998-07-13 2003-01-23 University Of Southern California Methods for accelerating bone and cartilage growth and repair
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
CA2339330A1 (fr) 1998-08-13 2000-02-24 University Of Southern California Procede pour augmenter le debit sanguin vers le tissu ischemique
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
AU1792901A (en) 1999-12-16 2001-06-25 University Of Southern California Methods for treating and preventing diabetic complications
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
WO2001098325A1 (fr) * 2000-06-19 2001-12-27 University Of Southern California Procedes de traitement et de prevention de l'alopecie
US20060058238A1 (en) 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
AU2008335717A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US20090227507A1 (en) 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof
WO2011120032A1 (fr) * 2010-03-26 2011-09-29 University Of Southern California Méthodes pour traiter des lésions combinées de radiation et thermiques
US20120071397A1 (en) 2010-08-10 2012-03-22 University Of Southern California Methods for Hematopoietic Stem Cell Transplantation
MX2012010783A (es) * 2011-02-02 2012-11-23 Univ Southern California Metodos para tratar ulceras del pie diabetico.

Also Published As

Publication number Publication date
CN102858360B (zh) 2017-07-25
KR20120137365A (ko) 2012-12-20
AU2012212220B2 (en) 2013-04-04
EP2536422B1 (fr) 2014-04-30
CA2793515A1 (fr) 2012-08-09
US8207234B1 (en) 2012-06-26
ES2479765T3 (es) 2014-07-24
AU2012212220A1 (en) 2012-10-18
JP2014080425A (ja) 2014-05-08
WO2012106427A3 (fr) 2012-09-20
EA026440B1 (ru) 2017-04-28
EP2536422A2 (fr) 2012-12-26
EA201201296A1 (ru) 2013-02-28
WO2012106427A2 (fr) 2012-08-09
ZA201207340B (en) 2013-02-27
CO6592101A2 (es) 2013-01-02
US20120329729A1 (en) 2012-12-27
MX2012010783A (es) 2012-11-23
PE20130379A1 (es) 2013-04-13
CN102858360A (zh) 2013-01-02
US8207233B1 (en) 2012-06-26
JP2013523781A (ja) 2013-06-17
KR101514414B1 (ko) 2015-05-04
US8536231B2 (en) 2013-09-17
JP5469777B2 (ja) 2014-04-16
CL2012002560A1 (es) 2013-03-22
PT2536422E (pt) 2014-07-18
PL2536422T3 (pl) 2014-09-30
SG183960A1 (en) 2012-10-30
CA2793515C (fr) 2015-05-12
BR112013019513A2 (pt) 2019-06-11
DK2536422T3 (da) 2014-07-28
EP2536422B8 (fr) 2023-06-21

Similar Documents

Publication Publication Date Title
HK1180213A1 (en) Methods for treating diabetic foot ulcers
PL2526141T3 (pl) Sposób obróbki powierzchniowej
ZA201208219B (en) Method for treating wasterwater
IL225623A0 (en) Psoriasis treatment methods
GB2483750B (en) Anti-slip step treatment
EP2788002A4 (fr) Méthodes d'utilisation de la mésoporphyrine d'étain pour le traitement de l'hyperbilirubinémie
GB201108797D0 (en) Surface treatment method
EP2662092A4 (fr) Procédé pour sélectionner un patient destiné à recevoir un médicament pour traiter une septicémie
GB201121950D0 (en) Treatment process
ZA201308117B (en) Avian-based treatment
GB201105523D0 (en) Treatment method
EP2695540A4 (fr) Structure supérieure de chaussure
GB201108301D0 (en) IVlg treatment for patients with Myeloma
IL215567A0 (en) Process for surface treatment
EP2768536A4 (fr) Méthode de traitement des diabètes de type i et de type ii
GB201100455D0 (en) Methods relating to treatment
GB201119184D0 (en) Light treatment method
GB201119181D0 (en) Light treatment method
GB201118869D0 (en) Light treatment method
GB201105056D0 (en) Treatment process
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102266D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201102272D0 (en) Treatment